Medicine & Life Sciences
Child
100%
Pediatrics
84%
Neoplasms
70%
Rhabdomyosarcoma
54%
Pharmacokinetics
54%
anti-IGF-1R antibody A12
35%
Young Adult
32%
Sarcoma
30%
Ewing's Sarcoma
29%
Central Nervous System Neoplasms
28%
Osteosarcoma
28%
Crizotinib
27%
Neuroblastoma
23%
Acute Myeloid Leukemia
23%
temsirolimus
21%
Drug Therapy
21%
Vorinostat
20%
Irinotecan
20%
United States Food and Drug Administration
19%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19%
Maximum Tolerated Dose
19%
Progression-Free Survival
18%
Temozolomide
18%
Leukemia
16%
MK-1775
15%
T-Lymphocytes
14%
Therapeutics
14%
Clinical Trials
13%
Sorafenib
13%
Drug Development
13%
Neutropenia
13%
Vincristine
12%
Combination Drug Therapy
12%
Diffuse Intrinsic Pontine Glioma
12%
Aggressive Fibromatosis
11%
Bone Marrow
11%
Cyclophosphamide
11%
tanespimycin
11%
Regulatory T-Lymphocytes
11%
Dendritic Cells
11%
Anaplastic Lymphoma Kinase
11%
Appointments and Schedules
10%
Toll-Like Receptor 7
10%
Recurrence
10%
Safety
10%
Radiation
10%
Allogeneic Cells
10%